Alessandra Anna Prete, Valentina Angerilli, Francesca Bergamo, Valentina Vettore, Chiara De Toni, Rossana Intini, Krisida Cerma, Gianmarco Ricagno, Riccardo Cerantola, Eleonora Perissinotto, Antonio De Rosa, Carlotta Ceccon, Jessica Gasparello, Luca Denaro, Alberto D'Amico, Franco Chioffi, Elena Carcea, Matteo Fassan, Sara Lonardi
BACKGROUND: Little is known about prognostic factors of brain metastases (BM) from colorectal cancer (CRC). HER2 amplification/overexpression (HER2+) was previously described; its impact on prognosis remains uncertain. METHODS: In the translational study HEROES, extensive molecular analysis was performed on primary CRC (prCRC) and their matched resected BM by means of NGS comprehensive genomic profiling and HER2 status as assessed by immunohistochemical/ in situ hybridization...
February 12, 2024: British Journal of Cancer